Cite
MLA Citation
Pierre N. Tariot et al.. “The Alzheimer's Prevention Initiative Autosomal‐Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical PSEN1 E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal‐dominant Alzheimer's disease, including a placebo‐treated noncarrier cohort.” Alzheimer's & dementia, vol. 4, no. 1, 2018, pp. 150–160. http://access.bl.uk/ark:/81055/vdc_100103187074.0x000008